| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.3 | 8e-09 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-08 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-08 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-06 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |